Stocktoria
ATOSSA THERAPEUTICS, INC. ATOS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-11-08
ATOSSA THERAPEUTICS, INC. statistics & valuation
Market cap$18.8M
P / B0.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -73.0% | -33.4% | -31.3% | -21.8% | -14.6% |
| Return on equity | -88.4% | -35.7% | -33.1% | -22.9% | -14.9% |
| Current ratio | 5.53 | 14.99 | 17.61 | 21.23 | 45.18 |
Source: SEC EDGAR filings · CIK 0001488039 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.